Go Pro

Seer (SEER) Competitors

Seer logo
$1.95 +0.01 (+0.52%)
As of 04:00 PM Eastern

SEER vs. TKNO, SLP, LAB, CDXS, and QSI

Should you buy Seer stock or one of its competitors? Seer's main competitors and comparable companies include Alpha Teknova (TKNO), Simulations Plus (SLP), Standard BioTools (LAB), Codexis (CDXS), and Quantum-Si (QSI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Seer compare to Alpha Teknova?

Alpha Teknova (NASDAQ:TKNO) and Seer (NASDAQ:SEER) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and risk.

In the previous week, Seer had 3 more articles in the media than Alpha Teknova. MarketBeat recorded 3 mentions for Seer and 0 mentions for Alpha Teknova. Seer's average media sentiment score of 0.38 beat Alpha Teknova's score of 0.00 indicating that Seer is being referred to more favorably in the news media.

Company Overall Sentiment
Alpha Teknova Neutral
Seer Neutral

Alpha Teknova has a beta of 0.72, meaning that its share price is 28% less volatile than the broader market. Comparatively, Seer has a beta of 1.5, meaning that its share price is 50% more volatile than the broader market.

Alpha Teknova has higher revenue and earnings than Seer. Alpha Teknova is trading at a lower price-to-earnings ratio than Seer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Teknova$40.52M9.16-$17.26M-$0.31N/A
Seer$16.58M6.51-$73.60M-$1.22N/A

13.8% of Alpha Teknova shares are owned by institutional investors. Comparatively, 75.2% of Seer shares are owned by institutional investors. 13.2% of Alpha Teknova shares are owned by insiders. Comparatively, 11.3% of Seer shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Alpha Teknova presently has a consensus target price of $7.50, indicating a potential upside of 8.38%. Seer has a consensus target price of $4.00, indicating a potential upside of 105.13%. Given Seer's stronger consensus rating and higher probable upside, analysts plainly believe Seer is more favorable than Alpha Teknova.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Teknova
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Seer
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
3.00

Alpha Teknova has a net margin of -38.37% compared to Seer's net margin of -478.05%. Alpha Teknova's return on equity of -24.94% beat Seer's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Teknova-38.37% -24.94% -16.53%
Seer -478.05%-27.23%-23.99%

Summary

Alpha Teknova beats Seer on 9 of the 17 factors compared between the two stocks.

How does Seer compare to Simulations Plus?

Simulations Plus (NASDAQ:SLP) and Seer (NASDAQ:SEER) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk and dividends.

78.1% of Simulations Plus shares are held by institutional investors. Comparatively, 75.2% of Seer shares are held by institutional investors. 19.1% of Simulations Plus shares are held by insiders. Comparatively, 11.3% of Seer shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Simulations Plus and Simulations Plus both had 3 articles in the media. Simulations Plus' average media sentiment score of 1.23 beat Seer's score of 0.38 indicating that Simulations Plus is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Simulations Plus
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Seer
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Simulations Plus has higher revenue and earnings than Seer. Seer is trading at a lower price-to-earnings ratio than Simulations Plus, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Simulations Plus$79.18M4.71-$64.72M$0.4046.08
Seer$16.58M6.51-$73.60M-$1.22N/A

Simulations Plus presently has a consensus price target of $17.25, suggesting a potential downside of 6.40%. Seer has a consensus price target of $4.00, suggesting a potential upside of 105.13%. Given Seer's stronger consensus rating and higher possible upside, analysts clearly believe Seer is more favorable than Simulations Plus.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Simulations Plus
1 Sell rating(s)
7 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.88
Seer
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
3.00

Simulations Plus has a net margin of 9.88% compared to Seer's net margin of -478.05%. Simulations Plus' return on equity of 13.50% beat Seer's return on equity.

Company Net Margins Return on Equity Return on Assets
Simulations Plus9.88% 13.50% 12.45%
Seer -478.05%-27.23%-23.99%

Simulations Plus has a beta of 1.33, meaning that its stock price is 33% more volatile than the broader market. Comparatively, Seer has a beta of 1.5, meaning that its stock price is 50% more volatile than the broader market.

Summary

Simulations Plus beats Seer on 10 of the 15 factors compared between the two stocks.

How does Seer compare to Standard BioTools?

Standard BioTools (NASDAQ:LAB) and Seer (NASDAQ:SEER) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation.

Standard BioTools has a net margin of 100.36% compared to Seer's net margin of -478.05%. Standard BioTools' return on equity of -7.57% beat Seer's return on equity.

Company Net Margins Return on Equity Return on Assets
Standard BioTools100.36% -7.57% -6.14%
Seer -478.05%-27.23%-23.99%

Standard BioTools presently has a consensus price target of $1.35, indicating a potential upside of 96.94%. Seer has a consensus price target of $4.00, indicating a potential upside of 105.13%. Given Seer's stronger consensus rating and higher possible upside, analysts clearly believe Seer is more favorable than Standard BioTools.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Standard BioTools
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67
Seer
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
3.00

In the previous week, Seer had 3 more articles in the media than Standard BioTools. MarketBeat recorded 3 mentions for Seer and 0 mentions for Standard BioTools. Seer's average media sentiment score of 0.38 beat Standard BioTools' score of 0.00 indicating that Seer is being referred to more favorably in the news media.

Company Overall Sentiment
Standard BioTools Neutral
Seer Neutral

53.7% of Standard BioTools shares are held by institutional investors. Comparatively, 75.2% of Seer shares are held by institutional investors. 26.8% of Standard BioTools shares are held by insiders. Comparatively, 11.3% of Seer shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Standard BioTools has a beta of 1.37, meaning that its share price is 37% more volatile than the broader market. Comparatively, Seer has a beta of 1.5, meaning that its share price is 50% more volatile than the broader market.

Seer has lower revenue, but higher earnings than Standard BioTools. Seer is trading at a lower price-to-earnings ratio than Standard BioTools, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Standard BioTools$85.33M3.15-$74.90M$0.223.12
Seer$16.58M6.51-$73.60M-$1.22N/A

Summary

Seer beats Standard BioTools on 9 of the 16 factors compared between the two stocks.

How does Seer compare to Codexis?

Codexis (NASDAQ:CDXS) and Seer (NASDAQ:SEER) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Codexis presently has a consensus target price of $6.50, indicating a potential upside of 345.21%. Seer has a consensus target price of $4.00, indicating a potential upside of 105.13%. Given Codexis' higher possible upside, research analysts clearly believe Codexis is more favorable than Seer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Codexis
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Seer
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
3.00

Codexis has a beta of 2.52, indicating that its stock price is 152% more volatile than the broader market. Comparatively, Seer has a beta of 1.5, indicating that its stock price is 50% more volatile than the broader market.

78.5% of Codexis shares are held by institutional investors. Comparatively, 75.2% of Seer shares are held by institutional investors. 3.5% of Codexis shares are held by company insiders. Comparatively, 11.3% of Seer shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Codexis has higher revenue and earnings than Seer. Codexis is trading at a lower price-to-earnings ratio than Seer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Codexis$70.39M2.27-$43.97M-$0.34N/A
Seer$16.58M6.51-$73.60M-$1.22N/A

Codexis has a net margin of -39.55% compared to Seer's net margin of -478.05%. Seer's return on equity of -27.23% beat Codexis' return on equity.

Company Net Margins Return on Equity Return on Assets
Codexis-39.55% -74.36% -23.58%
Seer -478.05%-27.23%-23.99%

In the previous week, Seer had 1 more articles in the media than Codexis. MarketBeat recorded 3 mentions for Seer and 2 mentions for Codexis. Codexis' average media sentiment score of 1.74 beat Seer's score of 0.38 indicating that Codexis is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Codexis
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Seer
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Codexis beats Seer on 10 of the 17 factors compared between the two stocks.

How does Seer compare to Quantum-Si?

Seer (NASDAQ:SEER) and Quantum-Si (NASDAQ:QSI) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation.

Seer has higher revenue and earnings than Quantum-Si. Quantum-Si is trading at a lower price-to-earnings ratio than Seer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Seer$16.58M6.51-$73.60M-$1.22N/A
Quantum-Si$2.44M68.71-$101.34M-$0.46N/A

75.2% of Seer shares are held by institutional investors. Comparatively, 39.9% of Quantum-Si shares are held by institutional investors. 11.3% of Seer shares are held by company insiders. Comparatively, 22.0% of Quantum-Si shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Seer has a net margin of -478.05% compared to Quantum-Si's net margin of -6,138.26%. Seer's return on equity of -27.23% beat Quantum-Si's return on equity.

Company Net Margins Return on Equity Return on Assets
Seer-478.05% -27.23% -23.99%
Quantum-Si -6,138.26%-47.12%-43.18%

In the previous week, Seer had 3 more articles in the media than Quantum-Si. MarketBeat recorded 3 mentions for Seer and 0 mentions for Quantum-Si. Seer's average media sentiment score of 0.38 beat Quantum-Si's score of 0.00 indicating that Seer is being referred to more favorably in the media.

Company Overall Sentiment
Seer Neutral
Quantum-Si Neutral

Seer currently has a consensus target price of $4.00, suggesting a potential upside of 105.13%. Quantum-Si has a consensus target price of $1.00, suggesting a potential upside of 30.55%. Given Seer's stronger consensus rating and higher probable upside, research analysts plainly believe Seer is more favorable than Quantum-Si.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Seer
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
3.00
Quantum-Si
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Seer has a beta of 1.5, suggesting that its share price is 50% more volatile than the broader market. Comparatively, Quantum-Si has a beta of 3.25, suggesting that its share price is 225% more volatile than the broader market.

Summary

Seer beats Quantum-Si on 12 of the 17 factors compared between the two stocks.

Get Seer News Delivered to You Automatically

Sign up to receive the latest news and ratings for SEER and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SEER and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SEER vs. The Competition

MetricSeerLife Sciences Tools & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$107.42M$10.03B$7.29B$12.92B
Dividend YieldN/A1.46%2.53%8.90%
P/E Ratio-1.6052.04211.9820.90
Price / Sales6.51112.07622.9295.01
Price / CashN/A27.0477.3952.28
Price / Book0.4835.9812.856.17
Net Income-$73.60M$56.67B$3.47B$349.50M
7 Day Performance-1.52%-0.83%1.24%-0.05%
1 Month Performance-11.76%4.54%5.81%0.80%
1 Year Performance-2.99%26.48%25.75%15.62%

Seer Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SEER
Seer
3.4547 of 5 stars
$1.95
+0.5%
$4.00
+105.1%
-4.0%$107.42M$16.58MN/A160
TKNO
Alpha Teknova
1.3633 of 5 stars
$7.10
-2.9%
$7.50
+5.6%
+70.4%$380.63M$40.52MN/A240
SLP
Simulations Plus
1.352 of 5 stars
$18.41
-0.1%
$17.25
-6.3%
+28.1%$372.34M$82.06M46.03160
LAB
Standard BioTools
3.0579 of 5 stars
$0.65
-1.0%
$1.35
+108.8%
-47.8%$253.84M$84.60M2.94620
CDXS
Codexis
4.0864 of 5 stars
$1.61
-3.3%
$6.50
+305.0%
-41.1%$175.76M$70.39MN/A250

Related Companies and Tools


This page (NASDAQ:SEER) was last updated on 9/4/2026 by MarketBeat.com Staff.
From Our Partners